Your search history is turned on.
Date: April 24, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - AntibeTherapeutics-042424 Antibe Announces Appointment of Receiver TORONTO--(BUSINESS WIRE)--April 24, 2024--Antibe Therapeutics Inc. (Antibe or the Company) (TSX: ATE) announced that the Companys request for an extension of its previously announced stay of proceedings under the Companies Creditors Arrangement Act (the CCAA) was heard before...
Date: April 19, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - Antibe - 04.19.24 Antibe Provides Update on CCAA Proceedings TORONTO--(BUSINESS WIRE)--April 19, 2024--Antibe Therapeutics Inc. (Antibe or the Company) (TSX: ATE) announced that the Company sought an extension of its previously announced stay of proceedings (Stay) under the Companies Creditors Arrangement Act (the CCAA) at a hearing before ...
Date: April 16, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Antibe Announces TSX Delisting Review ...
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act TORONTO--(BUSINESS WIRE)--April 9, 2024--Antibe Therapeutics Inc. (Antibe or the Company) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial ...
Microsoft Word - a53926266-release.htm Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act TORONTO--(BUSINESS WIRE)--April 9, 2024--Antibe Therapeutics Inc. (Antibe or the Company) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (t...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - Antibe 040124 Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance TORONTO--(BUSINESS WIRE)--April 1, 2024--Antibe Therapeutics Inc. (Antibe or the Company TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (FDA) that ot...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
ANTIBE Holdings to Therapeutics LicenseAgreement v1c Page 1 DOCSTOR: 5329961\3 DISTRIBUTION, LICENSE AND SUPPLY AGREEMENT THIS AGREEMENT, effective November 13th, 2015, by and between ANTIBE THERAPEUTICS INC., a corporation formed under the laws of Ontario (Licensor) and KNIGHT THERAPEUTICS INC., a corporation incorporated under the laws of Canad...
ANTIBE Holdings to Therapeutics LicenseAgreement v1c . CONFIDENTIAL IN WITNESS WHEREOF, the Parties by their respective authorized representatives, have executed this Agreement on this 27 day of March, 2017. ANTIBE THEREAPEUTICS INC. KNIGHT THERAPEUTICS (BARBADOS) INC.. Per: Per: Dan Legault President and Chief...
Page 1 DISTRIBUTION, LICENSE AND SUPPLY AGREEMENT THIS AGREEMENT, effective February 24th 2017, by and between ANTIBE THERAPEUTICS INC., a corporation formed under the laws of Ontario (Antibe) and LABORATOIRES ACBEL SA, a corporation incorporated under the laws of Switzerland (Acbel). RECITALS WHEREAS Antibe owns or licenses all right, title and intere...
Date: March 20, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - a53912791-release.htm Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting - The American Society of Regional Anesthesia and Pain Medicine is the largest subspecialty medical society in anesthesiology TORONTO--(BUSINESS WIRE)--March 20, 2024--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechn...